肾周肿瘤评分系统在腹膜后机器人辅助肾部分切除术中的外部验证
该研究对322例接受腹膜后机器人辅助肾部分切除术的患者进行了RENAL、PADUA和SPARE三种肾周肿瘤评分系统的外部验证。结果显示三种评分系统均与主要术中变量显著相关,但仅PADUA和SPARE能够预测Trifecta(三联指标)的达成,其中PADUA的AUC为0.623,SPARE的AUC为0.612。因此研究者推荐使用SPARE系统,因其为PADUA的简化版本且结果相当。
要点
- 三种评分系统均与手术时间、热缺血时间和估计出血量显著相关。
- 仅PADUA和SPARE能预测Trifecta达成,PADUA的AUC为0.623,SPARE为0.612。
- 推荐使用SPARE系统,因其为PADUA的简化版本且结果相当。
核心结论
- RENAL、PADUA和SPARE评分系统在腹膜后RAPN中能预测关键术中 outcomes,但仅PADUA和SPARE能预测Trifecta达成。
- 推荐使用SPARE系统,因其为PADUA的简化版本且结果相当。
研究设计与样本
- 外部验证研究,纳入2017年起在一家三级转诊中心连续接受腹膜后RAPN的322例患者,排除多发性肿瘤患者。
主要发现
- 所有三种评分系统均与手术时间、热缺血时间和估计出血量显著相关(连续变量和分类变量)。
- 仅PADUA和SPARE能预测Trifecta达成(PADUA AUC 0.623,95%CI 0.559-0.668;SPARE AUC 0.612,95%CI 0.548-0.677)。
关键数值与推荐
- Trifecta定义为热缺血时间<25分钟、无围手术期并发症和手术切缘阴性。
- PADUA评分预测Trifecta的AUC为0.623(95%CI 0.559-0.668),SPARE评分的AUC为0.612(95%CI 0.548-0.677)。
临床怎么用
- 在腹膜后RAPN术前评估中,可使用PADUA或SPARE评分系统预测Trifecta达成情况。
- 鉴于SPARE为PADUA的简化版本且预测能力相当,推荐优先使用SPARE系统。
局限性
- 本研究为单中心回顾性研究,样本量有限(322例),外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To externally validate the RENAL, PADUA and SPARE nephrometry scoring systems for use in retroperitoneal robot-assisted partial nephrectomy (RAPN). MATERIALS AND METHODS: Nephrometry scores were calculated for 322 consecutive patients receiving retroperitoneal RAPN at a tertiary referral centre from 2017. Patients with multiple tumours were excluded. Scores were correlated with peri-operative outcomes, including the trifecta (warm ischaemia time <25 min, no peri-operative complications and a negative surgical margin), both as continuous and categorical variables. Comparisons were performed using Spearman correlation and ability to predict the trifecta was assessed using binomial logistical regression. RESULTS: All three scoring systems correlated significantly with the main variables (operating time, warm ischaemia time and estimated blood loss), both as continuous and categorical variables. Only PADUA and SPARE were able to predict achievement of the trifecta (PADUA area under the curve [AUC] 0.623, 95% confidence interval [CI] 0.559-0.668; SPARE AUC 0.612, 95% CI 0.548-0.677). CONCLUSION: This study validates the RENAL, PADUA and SPARE scoring systems to predict key intra-operative outcomes in retroperitoneal RAPN. Only PADUA and SPARE were able to predict achievement of the trifecta. As a simplified version of the PADUA scoring system with comparable outcomes, we recommend using the SPARE system.
引用
- Crockett MG, Giona S, Whiting D, et al. Nephrometry scores: a validation of three systems for peri-operative outcomes in retroperitoneal robot-assisted partial nephrectomy. BJU Int. 2021. PMID: 33001563. doi:10.1111/bju.15262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。